ISN-Advancing Clinical Trials (ACT)

The ISN-ACT is an initiative of the ISN intended to leverage existing infrastructures within ISN, in order to improve global nephrology community participation in clinical trial research, through a series of activities and initiatives.

To generate more high-quality clinical trials and studies in nephrology, ISN-ACT (Advancing Clinical Trials) is calling on investigators and interested individuals to join this initiative. Let’s grow the capacity of the global nephrology community to lead and participate in clinical trials, by contributing to a range of initiatives, increasing collaboration and sharing experiences.


The aim of ISN-ACT is to increase the number of international high-quality clinical trials in nephrology, informing the optimal prevention and treatment of kidney disease and its complications for the benefit of patients. 

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact